Get started
Author

Mouna Sassi-Sayadi

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
2022 · Markus P Schlaich, Marc Bellet, et al. · The Lancet · 268
PDF
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
2022 · Dieter Kunz, Yves Dauvilliers, et al. · CNS Drugs · 117
PDF
Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension
2025 · Patrick Rossignol, Martine Clozel, et al. · Hypertension · 12
Aprocitentan for Blood Pressure Reduction in Black Patients
2025 · John M. Flack, Markus P. Schlaich, et al. · Hypertension · 11
Effects of Aprocitentan for Blood Pressure Lowering and Proteinuria in Patients with CKD and Resistant Hypertension
2023 · George L. Bakris, John M. Flack, et al. · Journal of the American Society of Nephrology · 3
Long-term safety and efficacy of daridorexant in patients with insomnia disorder
2022 · D. Kunz, H. Beneš, et al. · Sleep Medicine · 3
Regulatory Experiences with the Use of Multiple Imputation for Missing Data in a Phase 3 Confirmatory Trial
2025 · Mouna Sassi-Sayadi, Pierre Verweij, et al. · Therapeutic Innovation & Regulatory Science · 2
PDF
Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension
2025 · Markus P. Schlaich, Michael A. Weber, et al. · Journal of Hypertension · 1
Effect of Aprocitentan on Blood Pressure and Albuminuria in Patients With Resistant Hypertension Treated With Sodium-glucose Cotransporter-2 Inhibitors (sglt2i)
2025 · JI-Guang Wang, John M. Flack, et al. · Journal of the American College of Cardiology · 1
Abstract 19: Effect of the endothelin receptor antagonist aprocitentan on plasma endothelin, renin and aldosterone concentrations in patients with resistant hypertension. A biomarker analysis of the PRECISION study.
2024 · Marc Iglarz, Peter Blattmann, et al. · Hypertension · 1
Abstract P442: Impact of arterial stiffness on the blood pressure lowering effect of the dual endothelin antagonist aprocitentan in patients with resistant hypertension
2024 · Markus Schlaich, George Bakris, et al. · Hypertension · 1
Abstract P438: Is aprocitentan also sympatholytic in patients with resistant hypertension?
2024 · Martine Clozel, Mouna Sassi-Sayadi, et al. · Hypertension · 1
Abstract 118: Effects Of Aprocitentan, A Dual Endothelin Receptor Antagonist, On Blood Pressure In Black/African American Patients With Resistant Hypertension: Results From A Randomized, Controlled Study (PRECISION) Including A Withdrawal Phase
2023 · John M Flack, Markus Schlaich, et al. · Hypertension · 1
Abstract 4134333: Blood pressure reduction in diabetic patients with resistant hypertension: results from the aprocitentan PRECISION study
2024 · John Flack, George Bakris, et al. · Circulation
Abstract 4134327: Efficacy and safety of aprocitentan in patients with resistant hypertension receiving at least 4 antihypertensive medications including beta (β) blockers
2024 · Michael Weber, George Bakris, et al. · Circulation
Incidence and Prevalence of Edema and the Effect of Aprocitentan Treatment Strategy in the PRECISION Study
2024 · Markus P. Schlaich, George L. Bakris, et al. · Journal of the American Society of Nephrology
Abstract MP07: Efficacy and safety of aprocitentan in patients with resistant hypertension and elevated NT-proBNP
2024 · Michael Weber, George Bakris, et al. · Hypertension
Abstract P437: Correlation between plasma CT-proET-1 and renal dysfunction in patients with resistant hypertension. A biomarker analysis of the PRECISION study.
2024 · Peter Blattmann, Marc Iglarz, et al. · Hypertension
Abstract 28: A major effect of aprocitentan on albuminuria in patients with resistant hypertension
2024 · Markus Schlaich, George Bakris, et al. · Hypertension
Effect of High Dose Aprocitentan in Patients With Resistant Hypertension Not Controlled by Low Dose
2024 · Krzysztof Narkiewicz, Parisa Danaietash, et al. · Journal of Hypertension
Blood Pressure Control With Aprocitentan in Resistant Hypertension
2024 · Krzysztof Narkiewicz, Parisa Danaietash, et al. · Journal of Hypertension
Efficacy of long-term treatment with daridorexant in patients with insomnia disorder on sleep and daytime functioning: a post-hoc analysis
2022 · Y. Dauvilliers, H. Beneš, et al. · Sleep Medicine
Works count: 22
Citation count: 422
H-index: 4
I10-index: 4
Year
Topic
Type